Ces 3 Nouveaux traitements pourraient STOPPER la calvitie !!!

Introduction to Next-Gen Treatments00:00:00

The video introduces three promising anti-hair loss treatments that aim to overcome the side effects of current solutions like finasteride and oral minoxidil, backed by serious clinical research.

Clascoterone (Breezula)00:01:20

Clascoterone is a topical DHT blocker that acts locally at the hair follicle level. By avoiding systemic hormonal impact, it offers high tolerance and significant hair density improvements in recent trials, with a potential market release around 2026.

VDPHL01 (Extended-Release Minoxidil)00:03:16

VDPHL01 is a new, patented form of oral minoxidil designed with an extended-release mechanism. This aims to minimize cardiovascular side effects while providing a stable, officially authorized treatment for hair loss.

PP405 (Regenerative Treatment)00:04:44

PP405 represents a revolutionary approach by targeting dormant stem cells in hair follicles to reactivate them. Preliminary data shows promising results even in completely bald areas, positioning it as a leading regenerative candidate.

Future Outlook and Conclusion00:06:20

The presenter concludes that these treatments signal a shift toward more effective and better-tolerated solutions. While they are still in clinical phases, they offer a realistic hope for the future of hair loss management.